Share capital increaseSpecial resolutionCompanies ActDeclaratory reliefPrescription
Tags
Company LawShare CapitalDeclaratory Relief
legislation
Statutes Cited
High Court Act
Companies Act
Companies Act
Companies Act
Prescription Act
ai analysis
Case Summary
Key Issues
{"issue_text":"Whether the application has prescribed under the Prescription Act","issue_type":"procedural","dispositive":"yes","related_facts":"Timeline of events from 2006 to 2023, participation in dividends"}
{"issue_text":"Whether the answering affidavit was properly filed within the five-day period","issue_type":"procedural","dispositive":"yes","related_facts":"Notice of opposition filed 20 April 2023, answering affidavit filed 5 May 2023"}
{"issue_text":"Whether the cause of action is competent given that company documents have not been set aside","issue_type":"procedural","dispositive":"no","related_facts":"Share register, annual returns, and special resolution not challenged in competent court"}
{"issue_text":"Whether the application is replete with material non-disclosure","issue_type":"procedural","dispositive":"no","related_facts":"Failure to disclose that 17 out of 23 members participated in rights issue"}
This summary was generated by AI. Use Zalari to read the full judgment.
background
Facts of the Case
Background
Applicants sought a declaratur that the registered nominal shares of the 1st respondent total 24,000 shares, challenging an alleged unlawful increase from 24,000 to 47,500 shares in 2006. Respondents opposed on grounds of prescription, lack of authority, and material non-disclosure.
Read the full judgment, get AI analysis, and find related cases